• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Cellebrite Government Cloud Platform Achieves FedRAMP High Ready Status

    2/12/25 8:30:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology
    Get the next $CLBT alert in real time by email

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in Digital Investigative (DI) solutions for the public and private sectors, announced today that its Cellebrite Government Cloud platform has achieved FedRAMP High Ready designation by the Federal Risk and Authorization Management Program (FedRAMP). This milestone, which marks the initial stage in the compliance process, reinforces Cellebrite's commitment to equipping and empowering its U.S. federal customers with industry-leading cloud security when utilizing the Company's Software-as-a-Service-based digital investigative solutions.

    Since announcing its intent to pursue FedRAMP authorization, the Cellebrite Government Cloud was reviewed by a Third-Party Assessment Organization (3PAO), and the FedRAMP Program Management Office (PMO) prepared a Readiness Assessment Report (RAR) which granted Cellebrite Government Cloud FedRAMP High Ready status. This thorough review ensures Cellebrite's cloud and security services meet the rigorous standards required by the FedRAMP Compliance Regulations. Cellebrite's FedRAMP activities are supported by Coalfire, a global leader in cybersecurity services and solutions, and leverage the Company's long-standing relationship with Amazon Web Services (AWS).

    "We are proud to reach the FedRAMP High Ready stage with the Cellebrite Government Cloud," said Erik Sachwitz, General Manager of Cellebrite Federal Solutions, Inc. "Today's milestone represents another important step that Cellebrite has taken over the past year to further expand the scope of our relationships with U.S. Federal agencies. We are excited about the opportunity to provide our U.S. Federal customers with trusted, secure and innovative cloud-ready solutions that help modernize their investigative workflows and accelerate their missions."

    Cellebrite's Government Cloud will initially support Cellebrite Inseyets, the Company's market-leading digital forensics solution, with the scalability and security to address the requirements of U.S. Federal agencies as well as other national, regional and local public safety customers around the globe. Future offerings on the Cellebrite Government Cloud include the Company's leading secure, scalable cloud solution, Cellebrite Guardian, for digital evidence sharing, review and management. Guardian delivers greater operational efficiencies, supports better collaboration and helps advance missions, strengthening the overall chain of custody.

    References to Websites and Social Media Platforms

    References to information included on, or accessible through, websites and social media platforms do not constitute incorporation by reference of the information contained at or available through such websites or social media platforms, and you should not consider such information to be part of this press release.

    About Cellebrite

    Cellebrite's (NASDAQ:CLBT) mission is to enable its global customers to protect and save lives by enhancing digital intelligence and accelerating justice in communities around the world. Cellebrite's AI-powered Case-to-Closure (C2C) platform enables customers to lawfully access, collect, analyze and share digital evidence in legally sanctioned investigations while preserving data privacy. Thousands of public safety organizations, intelligence agencies and businesses rely on the Company's cloud-ready digital forensic and investigative solutions to close cases faster and safeguard communities. To learn more, visit us at www.cellebrite.com, https://investors.cellebrite.com and find us on social media @Cellebrite.

    Caution Regarding Forward Looking Statements

    This document includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward looking statements may be identified by the use of words such as "forecast," "intend," "seek," "target," "anticipate," "will," "appear," "approximate," "foresee," "might," "possible," "potential," "believe," "could," "predict," "should," "could," "continue," "expect," "estimate," "may," "plan," "outlook," "future" and "project" and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include that we are excited about the opportunities we see to provide our U.S. Federal customers with trusted, secure and innovative cloud-ready solutions that help modernize their investigative workflows and accelerate justice; Cellebrite's Government Cloud will initially support Cellebrite Inseyets, the Company's market-leading digital forensics solution, with the scalability and security to address the requirements of U.S. Federal agencies as well as other national, regional and local public safety customers around the globe; and future offerings on the Cellebrite Government Cloud include the Company's leading secure, scalable cloud solution, Guardian, for digital evidence sharing, review and management. Such forward-looking statements are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to: Cellebrite's ability to continue advancing its FedRAMP activities to achieve full FedRAMP authorization in a timely manner; Cellebrite's ability to keep pace with technological advances and evolving industry standards; Cellebrite's material dependence on the purchase, acceptance and use of its solutions by law enforcement and government agencies; real or perceived errors, failures, defects or bugs in Cellebrite's DI solutions; Cellebrite's failure to maintain the productivity of sales and marketing personnel, including relating to hiring, integrating and retaining personnel; intense competition in all of Cellebrite's markets; the inadvertent or deliberate misuse of Cellebrite's solutions; failure to manage its growth effectively; Cellebrite's ability to introduce new solutions and add-ons; Cellebrite's dependency on its customers renewing their subscriptions and purchasing new subscriptions; the low volume of business Cellebrite conducts via e-commerce; risks associated with the use of artificial intelligence; the risk of requiring additional capital to support the growth of its business; risks associated with Cellebrite's dependency on third parties for supplying components or services and with higher costs or unavailability of materials used to create its hardware product components; lengthy sales cycle for some of Cellebrite's solutions; near term declines in new or renewed agreements; risks associated with inability to recruit, train and retain qualified personnel and senior management; the security of Cellebrite's operations and the integrity of its software solutions against cyber-attacks, information technology system breaches or disruptions; risks associated with the negative publicity related to Cellebrite's business and use of its products; risks related to Cellebrite's intellectual property; the regulatory constraints to which Cellebrite is subject; risks associated with Cellebrite's operations in Israel, including the ongoing Israel-Hamas war, the increased tension between Israel and Iran and its proxies, including the ongoing hostilities between Israel and Hezbollah, and the risk of a greater regional conflict; risks associated with different corporate governance requirements applicable to Israeli companies and risks associated with being a foreign private issuer and an emerging growth company; market volatility in the price of Cellebrite's shares; changing tax laws and regulations; risks associated with joint, ventures, partnerships and strategic initiatives; risks associated with Cellebrite's significant international operations, including due to fluctuations in foreign currency exchange rates, rising global inflation and exposure to regions subject to political or economic instability; risks associated with Cellebrite's failure to comply with anti-corruption, trade compliance, anti-money-laundering and economic sanctions laws and regulations; risks relating to the adequacy of Cellebrite's existing systems, processes, policies, procedures, internal controls and personnel for Cellebrite's current and future operations and reporting needs; and other factors, risks and uncertainties set forth in the section titled "Risk Factors" in Cellebrite's annual report on Form 20-F filed with the SEC on March 21, 2024 and as amended on April 12, 2024, and in other documents filed by Cellebrite with the U.S. Securities and Exchange Commission ("SEC"), which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

    Media 

    Victor Cooper 

    Sr. Director of Corporate Communications + Content Operations 

    [email protected] 

    +1 404.804.5910 

    Investor Relations 

    Andrew Kramer 

    Vice President, Investor Relations 

    [email protected] 

    +1 973.206.7760 



    Primary Logo

    Get the next $CLBT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLBT

    DatePrice TargetRatingAnalyst
    3/28/2024$13.00 → $13.50Buy
    Needham
    3/13/2024Mkt Perform → Outperform
    William Blair
    2/16/2024$9.00 → $12.00Neutral → Buy
    BofA Securities
    7/19/2023$11.00Buy
    Craig Hallum
    8/12/2022$6.50 → $6.00Buy → Neutral
    BofA Securities
    8/12/2022Outperform → Mkt Perform
    William Blair
    2/24/2022$10.50Overweight
    JP Morgan
    2/11/2022$10.50Buy
    Deutsche Bank
    More analyst ratings

    $CLBT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cellebrite Unveils Spring 2025 Release to Accelerate Global Investigations

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 06, 2025 (GLOBE NEWSWIRE) --  Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced its Spring 2025 Release, featuring a new cloud foundation and AI-powered innovations across its portfolio. These enhancements are already playing an important role in helping customers modernize their digital workflows, speed up their investigations and elevate operational productivity and efficiency. The Spring 2025 Release introduces the Cellebrite Cloud, which delivers a purpose-built user experience that scales investigative capabilities and accelerates decision-making acro

      5/6/25 8:30:00 AM ET
      $AMZN
      $CLBT
      Catalog/Specialty Distribution
      Consumer Discretionary
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite to Report First-Quarter 2025 Financial Results on May 14, 2025

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its first-quarter 2025 financial results before market open on Wednesday, May 14, 2025. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the first quarter of 2025 and discuss its full-year 2025 outlook. Relevant details include: Date:Wednesday, May 14, 2025Time:8:30 a.m. ETCall-In Number:203-518-9783 / 800-267-6316Conference ID:CLBTQ125Event URL:https://investors.cellebrite.com/events/

      4/10/25 8:30:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • 10 Winners Awarded "Justies" at Cellebrite's First-Ever Digital Justice Awards

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 01, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in Digital Investigative (DI) solutions for the public and private sectors, awarded ten winners "Justies" at the Company's inaugural Digital Justice Awards. Held at The National Law Enforcement Museum in Washington, DC, Cellebrite rolled out the orange carpet to celebrate some of the brightest minds and sharpest technical skillsets in digital investigations. "It was inspiring to celebrate those who tirelessly protect their communities," said Tom Hogan, Cellebrite's chief executive officer. "The evening shined a bright light on the courage, passion and dedication of thes

      4/1/25 8:30:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13D/A filed by Cellebrite DI Ltd.

      SCHEDULE 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)

      3/20/25 4:30:03 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 20-F filed by Cellebrite DI Ltd.

      20-F - Cellebrite DI Ltd. (0001854587) (Filer)

      3/18/25 7:04:55 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 144 filed by Cellebrite DI Ltd.

      144 - Cellebrite DI Ltd. (0001854587) (Subject)

      2/28/25 4:04:55 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Cellebrite DI Ltd.

      SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)

      9/17/24 4:33:52 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Amendment: SEC Form SC 13D/A filed by Cellebrite DI Ltd.

      SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)

      8/29/24 6:07:01 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Cellebrite DI Ltd. (Amendment)

      SC 13G/A - Cellebrite DI Ltd. (0001854587) (Subject)

      3/12/24 12:38:56 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    Financials

    Live finance-specific insights

    See more
    • Cellebrite to Report First-Quarter 2025 Financial Results on May 14, 2025

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its first-quarter 2025 financial results before market open on Wednesday, May 14, 2025. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the first quarter of 2025 and discuss its full-year 2025 outlook. Relevant details include: Date:Wednesday, May 14, 2025Time:8:30 a.m. ETCall-In Number:203-518-9783 / 800-267-6316Conference ID:CLBTQ125Event URL:https://investors.cellebrite.com/events/

      4/10/25 8:30:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite Announces Fourth-Quarter and Full-Year 2024 Results

      Company delivers "Rule of 50" Performance in 2024 with 25% ARR growth and 25% adjusted EBITDA margin Fourth-quarter 2024 revenue of $109.0 million grew 17% primarily due to21% growth in subscription revenue ARR grew 25% to $395.9 million Fourth-quarter 2024 adjusted EBITDA of $28.8 million, 26.4% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three and twelve months ending December 31, 2024. "Cellebrite delivered a solid fourth-quarter performance to cap an excellent 2024

      2/13/25 7:00:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite to Report Fourth-Quarter and Fiscal Year 2024 Financial Results on February 13, 2025

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its fourth-quarter and fiscal year 2024 financial results before market open on Thursday, February 13, 2025. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the fourth quarter of 2024 and discuss its 2025 outlook. Relevant details include: Date:Thursday, February 13, 2025Time:8:30 a.m. ETCall-In Number:203-518-9783 / 800-267-6316Conference ID:         CLBTQ424Event URL:https://investor

      1/10/25 8:00:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham reiterated coverage on Cellebrite DI with a new price target

      Needham reiterated coverage of Cellebrite DI with a rating of Buy and set a new price target of $13.50 from $13.00 previously

      3/28/24 8:25:08 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite DI upgraded by William Blair

      William Blair upgraded Cellebrite DI from Mkt Perform to Outperform

      3/13/24 7:29:30 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite DI upgraded by BofA Securities with a new price target

      BofA Securities upgraded Cellebrite DI from Neutral to Buy and set a new price target of $12.00 from $9.00 previously

      2/16/24 7:23:02 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    Leadership Updates

    Live Leadership Updates

    See more
    • Cellebrite Appoints Michael D. Capellas to Board of Directors as Lead Independent Director

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) --  Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a series of Board updates to support the Company's continued growth into 2025 and beyond. As previously detailed on November 6, 2024, Thomas E. Hogan has been appointed interim CEO to begin 2025 as part of a planned leadership transition. In conjunction with stepping into this position, Mr. Hogan remains on the Company's Board of Directors and plans to revert to his position as chairman upon the eventual appointment of a new CEO. As part of Cellebrite's ongoing commitment to

      1/6/25 8:00:00 AM ET
      $CLBT
      $CSCO
      Computer Software: Prepackaged Software
      Technology
      Computer Communications Equipment
      Telecommunications
    • Yossi Carmil to Step Down as CEO After Nearly 20 Years

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a planned leadership transition following Yossi Carmil's decision to step down from his current role as CEO and as a member of the Board of Directors by December 31, 2024. The Board has initiated a formal search for a new CEO, retaining an executive recruiting firm to advance this effort. Thomas E. Hogan, Cellebrite's executive chairman, will serve as interim CEO upon Carmil's departure and until the search is complete and a new CEO joins Cellebrite. "Cellebrite is indebted to

      11/6/24 8:20:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite Appoints Tech Veteran Troy K. Richardson to Board of Directors

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier digital investigative solutions for the public and private sectors, announced today that Troy Richardson has joined its board of directors, effective August 13, 2024. Mr. Richardson is a seasoned technology executive with more than 30 years of experience in leading, scaling and transforming global organizations. He currently serves on the Unisys Corporation (NYSE:UIS) Board of Directors and previously served as a Director of the Board for Carestream Dental. Mr. Richardson was president of the Digital Thread group at PTC Inc. (NASDAQ:PTC) from 2021 until 2022

      8/14/24 7:00:00 AM ET
      $CLBT
      $PTC
      $UIS
      Computer Software: Prepackaged Software
      Technology
      EDP Services